• Belinostat (PXD101): From HDAC to Splicing

  2026-08-17

  Belinostat (PXD101) is examined here as a mechanistic probe connecting histone deacetylase inhibition with cell-cycle control and spliceosome-linked DNA-repair research. The article translates HCC findings on SmD2 acetylation into practical, evidence-aware assay decisions without overstating belinostat-specific evidence.

• BRD4770: A Practical G9a Inhibition Workflow

  2026-08-17

  BRD4770 is a research-focused G9a histone methyltransferase inhibitor for connecting H3K9 methylation changes with senescence and tumor-cell fitness. This workflow emphasizes formulation control, orthogonal readouts, PANC-1 assays, and careful translation of breast-cancer pathway findings.

• MVC, RhoA/ROCK1 Signaling, and Viral Entry

  2026-08-16

  The reference study identifies a direct interaction between MVC VP2 and the ROCK1 kinase domain and links this interaction to activation of the RhoA/ROCK1/MLC2 axis, tight-junction disruption, and Occludin-dependent viral entry. Its inhibitor-rescue experiments provide a mechanistic framework for studying how cytoskeletal contractility regulates parvovirus infection in canine cells.

• NADH Reductive Stress in Leigh Syndrome

  2026-08-15

  This pilot study introduces streamlined LC-MS/MS quantification of NADH and NAD+ to examine reductive stress in patient-derived fibroblasts and an Ndufs4-knockout Leigh syndrome model. Elevated NADH, rather than loss of NAD+, tracked with the disease models, supporting direct redox measurement as a potential complement to lactate-based assessment.

• ZK53: Practical ClpP Assay Design

  2026-08-14

  Learn how ZK53 (SKU BA8004), a human mitochondrial serine protease ClpP activator, can support better-designed viability, proliferation, and cytotoxicity experiments. This scenario-based guide connects assay selection, concentration planning, mechanism validation, and product reliability to documented biochemical and cellular data.

• Ceftolozane/Tazobactam: Mechanism and Evidence

  2026-08-14

  The reference review examines ceftolozane/tazobactam as an antipseudomonal cephalosporin–β-lactamase inhibitor combination designed to address resistant gram-negative infections. Its main contributions are the synthesis of mechanism, resistance, pharmacokinetic, pharmacodynamic, animal, clinical, and safety evidence, with particular emphasis on PBP binding, activity against Pseudomonas aeruginosa, and exposure relative to the MIC.

• Toremifene Citrate in ER Assays

  2026-08-13

  A scenario-based guide to using Toremifene Citrate (SKU B1513) in estrogen receptor, cell viability, proliferation, and cytotoxicity workflows. It connects receptor pharmacology with practical dose selection, assay controls, formulation handling, and translational interpretation.

• FGFR1 as a Druggable Target in Schizophrenia

  2026-08-13

  A 2025 Molecular Neurobiology study integrated druggable-gene resources with schizophrenia GWAS and eQTL data to prioritize therapeutic targets using Mendelian randomization, colocalization, SMR, PheWAS, and molecular docking. FGFR1 emerged as a leading candidate, but the findings remain genetic and computational rather than evidence of clinical efficacy.

• PERK–JAK1–STAT3 Drives Disc Cell Pyroptosis

  2026-08-12

  The reference study identifies a mechanistic link between unresolved endoplasmic reticulum stress and pyroptosis in nucleus pulposus cells, showing that PERK/eIF2α/ATF4 signaling activates JAK1–STAT3. Its findings position this ER stress signaling pathway as a potential intervention point in intervertebral disc degeneration while clarifying why inflammatory cell death may intensify during persistent cellular stress.

• SD 169: A Mechanistic Guide to p38 Assays

  2026-08-12

  SD 169 (indole-5-carboxamide) is a selective ATP-competitive p38α/β inhibitor for dissecting stress-activated signaling. This guide translates recent kinase dephosphorylation findings into practical assay decisions for type 1 diabetes research, apoptosis assays, and axonal regeneration research.

• GSK343: Selective EZH2 Inhibitor Guide

  2026-08-11

  GSK343 is a cell-permeable, SAM-competitive EZH2 inhibitor for in vitro epigenetic cancer research. It suppresses EZH2-dependent H3K27me3 signaling, but its cellular potency and high animal-model clearance limit direct translational interpretation.

• gamma-Glu-Cys (γ-Glu-Cys): Lab Guide

  2026-08-11

  gamma-Glu-Cys (γ-Glu-Cys) provides a defined L-glutathione biosynthesis intermediate for glutathione synthetase enzyme assays, thiol-reactive peptide synthesis, and related plant studies. It is intended for controlled scientific workflows only; it should not be used for diagnostic, therapeutic, or medical applications, and prepared solutions should not be stored long term.

• Mitochondrial Calcium Signaling Represses Ferroptosis

  2026-08-10

  The reference study identifies a mechanistic connection between mitochondrial calcium uptake, acetyl-CoA metabolism, and GPX4 activity in ferroptosis suppression. Its genetic, biochemical, structural, and tumor-model evidence suggests that MCU-dependent signaling can preserve cancer-cell survival by sustaining an acetylated, functional GPX4 state.

• Minocycline HCl in Retinal Microglia Assays

  2026-08-09

  Minocycline HCl offers a practical pharmacological control for testing whether retinal amyloid clearance depends on microglial activity rather than light exposure alone. This workflow translates a 40-Hz flicker mouse study into reproducible preparation, assay, and troubleshooting decisions for inflammation and neuroprotection research.

• Platycodin D Targets RFC4 in Lung Cancer

  2026-08-08

  A 2026 Molecular & Cellular Proteomics study used thermal proteome profiling, peptide-centric stability analysis, cellular thermal shift assays, and multidimensional omics to identify RFC4 as a binding target of Platycodin D in non-small cell lung cancer models. The work connects RFC4 engagement with altered Notch1/Notch3 processing, ubiquitin-related remodeling, and cancer-cell apoptosis, while providing a transferable workflow for mechanism-focused natural-product research.

8628 records 3/576 page Previous Next 12345 下5页 Last page